ANI Pharmaceuticals | ANIP - Srodki Pieniężne I Ekwiwalent

Cena Akcji
74.17
Dzienna Zmiana
-0.11 -0.15%
Miesięcznie
-5.03%
Rocznie
14.34%
Q1 Prognozy TE
68.36




Srodki Pieniężne I Ekwiwalent Zmiana Data
AbbVie USD 5.23B 400M 2025-12
ANI Pharmaceuticals USD 285.58M 22.98M 2025-12
Assertio Holdings USD 38.5M 8.59M 2025-09
Aurora Cannabis CAD 95.69M 44.47M 2025-09
Canopy Growth CAD 298.06M 171.86M 2025-09
Eli Lilly USD 7.27B 2.52B 2025-12
Emergent BioSolutions USD 111.7M 23.9M 2023-12
Heron Therapeutics USD 43.07M 26.55M 2025-09
Hikma Pharmaceutical USD 236M 48M 2025-06
Knight Therapeutics CAD 81.88M 4.06M 2025-09
Nektar Therapeutics USD 41.03M 1.96M 2025-09
Novartis USD 9.56B 2.9B 2025-09
Omeros USD 1.9M 2.36M 2025-06
Perrigo USD 432.1M 22.1M 2025-09
Sun Pharmaceuticals INR 113.32B 33.19B 2025-03
Teva Pharmaceutical Industries USD 3.56B 1.35B 2025-12